Share-based Payment Arrangement, Expense of Processa Pharmaceuticals, Inc. from 30 Jun 2012 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Processa Pharmaceuticals, Inc. quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 30 Jun 2012 to 30 Sep 2025.
  • Processa Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the quarter ending 30 Sep 2025 was $303,047, a 97% increase year-over-year.
  • Processa Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the twelve months ending 30 Sep 2025 was $889,054.
  • Processa Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2024 was $629,514, a 73% decline from 2023.
  • Processa Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $2,371,214, a 73% decline from 2022.
  • Processa Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $8,828,713, a 458% increase from 2021.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

Processa Pharmaceuticals, Inc. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $889,054 $303,047 +$148,856 +97% 01 Jul 2025 30 Sep 2025 10-Q 06 Nov 2025 2025 Q3
Q2 2025 $740,198 $203,248 +$50,616 +33% 01 Apr 2025 30 Jun 2025 10-Q 07 Aug 2025 2025 Q2
Q1 2025 $689,582 $227,711 +$60,068 +36% 01 Jan 2025 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q4 2024 $629,514 $155,048 01 Oct 2024 31 Dec 2024 10-K 20 Mar 2025 2024 FY
Q3 2024 $154,191 01 Jul 2024 30 Sep 2024 10-Q 06 Nov 2025 2025 Q3
Q2 2024 $152,632 01 Apr 2024 30 Jun 2024 10-Q 07 Aug 2025 2025 Q2
Q1 2024 $167,643 01 Jan 2024 31 Mar 2024 10-Q 08 May 2025 2025 Q1
Q4 2019 $510,478 $116,314 01 Oct 2019 31 Dec 2019 10-K 06 Mar 2020 2019 FY
Q3 2019 $269,129 +$218,601 +433% 01 Jul 2019 30 Sep 2019 10-Q 14 Nov 2019 2019 Q3
Q2 2019 $66,476 01 Apr 2019 30 Jun 2019 10-Q 14 Aug 2019 2019 Q2
Q1 2019 $58,559 01 Jan 2019 31 Mar 2019 10-Q 14 May 2019 2019 Q1
Q3 2018 $50,528 01 Jul 2018 30 Sep 2018 10-Q 14 Nov 2019 2019 Q3
Q2 2016 $28,543 $1,629 -$37,896 -96% 01 Apr 2016 30 Jun 2016 10-Q 30 Aug 2017 2016 Q2
Q1 2016 $66,439 $5,062 -$30,490 -86% 01 Jan 2016 31 Mar 2016 10-Q 07 Aug 2017 2016 Q1
Q4 2015 $96,929 $12,751 -$8,919 -41% 01 Oct 2015 31 Dec 2015 10-K 25 Sep 2017 2016 FY
Q3 2015 $105,848 $9,101 -$37,032 -80% 01 Jul 2015 30 Sep 2015 10-Q 08 Sep 2017 2016 Q3
Q2 2015 $142,880 $39,525 +$5,212 +15% 01 Apr 2015 30 Jun 2015 10-Q 30 Aug 2017 2016 Q2
Q1 2015 $137,668 $35,552 -$93,856 -73% 01 Jan 2015 31 Mar 2015 10-Q 07 Aug 2017 2016 Q1
Q4 2014 $231,524 $21,670 -$127,194 -85% 01 Oct 2014 31 Dec 2014 10-K 19 Jun 2017 2015 FY
Q3 2014 $358,718 $46,133 +$28,607 +163% 01 Jul 2014 30 Sep 2014 10-Q 01 Dec 2015 2015 Q3
Q2 2014 $330,111 $34,313 +$3,942 +13% 01 Apr 2014 30 Jun 2014 10-Q 19 Aug 2015 2015 Q2
Q1 2014 $326,169 $129,408 +$110,086 +570% 01 Jan 2014 31 Mar 2014 10-Q 15 May 2015 2015 Q1
Q4 2013 $216,083 $148,864 01 Oct 2013 31 Dec 2013 10-K 14 Apr 2015 2014 FY
Q3 2013 $17,526 -$57,675 -77% 01 Jul 2013 30 Sep 2013 10-Q 13 Nov 2014 2014 Q3
Q2 2013 $30,371 -$42,997 -59% 01 Apr 2013 30 Jun 2013 10-Q 19 Aug 2014 2014 Q2
Q1 2013 $19,322 01 Jan 2013 31 Mar 2013 10-Q 14 May 2014 2014 Q1
Q3 2012 $75,201 01 Jul 2012 30 Sep 2012 10-Q 08 Nov 2013 2013 Q3
Q2 2012 $73,368 01 Apr 2012 30 Jun 2012 10-Q/A 06 Sep 2013 2013 Q2

Processa Pharmaceuticals, Inc. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $629,514 -$1,741,700 -73% 01 Jan 2024 31 Dec 2024 10-K 20 Mar 2025 2024 FY
2023 $2,371,214 -$6,457,499 -73% 01 Jan 2023 31 Dec 2023 10-K 20 Mar 2025 2024 FY
2022 $8,828,713 +$7,247,729 +458% 01 Jan 2022 31 Dec 2022 10-K 29 Mar 2024 2023 FY
2021 $1,580,984 +$1,197,413 +312% 01 Jan 2021 31 Dec 2021 10-K 30 Mar 2022 2021 FY
2020 $383,571 -$126,907 -25% 01 Jan 2020 31 Dec 2020 10-K 30 Mar 2022 2021 FY
2019 $510,478 +$436,415 +589% 01 Jan 2019 31 Dec 2019 10-K 06 Mar 2020 2019 FY
2018 $74,063 01 Jan 2018 31 Dec 2018 10-K 06 Mar 2020 2019 FY
2016 $6,691 -$90,238 -93% 01 Jan 2016 31 Dec 2016 10-K 25 Sep 2017 2016 FY
2015 $96,929 -$134,595 -58% 01 Jan 2015 31 Dec 2015 10-K 25 Sep 2017 2016 FY
2014 $231,524 +$15,441 +7.1% 01 Jan 2014 31 Dec 2014 10-K 19 Jun 2017 2015 FY
2013 $216,083 -$240,915 -53% 01 Jan 2013 31 Dec 2013 10-K 14 Apr 2015 2014 FY
2012 $456,998 01 Jan 2012 31 Dec 2012 10-K 27 Mar 2014 2013 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.